Medrad, Inc.: FDA filings under this applicant name

FDA lists 105 510(k) clearances under the applicant name “Medrad, Inc.” (first 1976, latest 2014), across 23 product codes in 5 review panels. Median 510(k) review time under this name: 75 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
20122116
2013298
20141335
20150—
20160—
20170—
20180—
20190—
20200—
20210—
20220—
20230—
20240—
20250—
20260—

Top product codes

Product codeDeviceSubmissions510(k) clearances
DXTInjector And Syringe, Angiographic3232
MOSCoil, Magnetic Resonance, Specialty1818
LNHSystem, Nuclear Magnetic Resonance Imaging1616
FRNPump, Infusion66
DQOCatheter, Intravascular, Diagnostic33
DQXWire, Guide, Catheter33
LLZSystem, Image Processing, Radiological33
MCWCatheter, Peripheral, Atherectomy33
QEZAspiration Thrombectomy Catheter33
DOYRadioimmunoassay, Digoxin (3-H), Goat Antibody, 2nd Antibody Sep.22

Plus 13 more product codes.

Review panels

Most recent Medrad, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K133023JETSTREAM XC 2.4/3.4; JETSTREAM XC 2.1/3.0; JETSTREAM SC 1.85; JETSTREAM SC 1.6MCW2014-08-27335
K130381ANGIOJET ULTRA POWER PULSE KITQEW2013-07-29165
K130637JETSTREAM XC 2.4/3.4 SYSTEM; JETSTREAM XC 2.1/3.0 SYSTEM; JETSTREAM SC 1.85 SYSTEM; JETSTREAM SC 1.6 SYSTEMMCW2013-04-1030
K122916JETSTREAM NAVITUS L SYSTEM JEYSTREAM NAVITUS SYSTEM JETSTREAM G3 SF SYSTEM JETSTREAM SF 1.6 SYSTEMMCW2012-10-1928
K113363ANGIOJET SOLENT DISTA THROMBECTOMY SETQEZ2012-06-06204
K113133MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM), (TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION ARTERION SYRINGEDXT2011-12-1552
K113428ANGIOJET ULTRA DVX THROMBECTOMY SETQEZ2011-12-0211
K112086MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM / TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION SYRINGEDXT2011-10-1485
K111182ANGIOJET SOLENT OMNI THROMBECTOMY SETQEZ2011-05-2427
K100798MEDRAD INTEGO PET INFUSION SYSTEM, SOURCE ADMINISTRATION SET, PATIENT ADMINSTRATIN SET MODEL INT SYS 100, INT CSS, INT CFRN2010-06-2393

95 earlier clearances. See the full list in Caduvo.

Recalls

29 product recalls in 17 recall events; 0 initiated in the last five years. Most recent: 2013-04-15.

13 product recalls in 11 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 2 initiated in the last five years. Most often: Bayer Medical Care, Inc. (5), Bayer Healthcare (3), Boston Scientific Corporation (3).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Medrad, Inc. (a text match, not an official crosswalk):

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Medrad, Inc.?

FDA lists 105 510(k) clearances under the applicant name “Medrad, Inc.” (first 1976, latest 2014), across 23 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Medrad, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Medrad, Inc. is 75 days.

Which FDA product codes appear under Medrad, Inc.?

The most frequent FDA product codes under this applicant name are DXT (Injector And Syringe, Angiographic, 32); MOS (Coil, Magnetic Resonance, Specialty, 18); LNH (System, Nuclear Magnetic Resonance Imaging, 16).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup